Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
Selective serotonin reuptake inhibitors (SSRIs) are increasingly prescribed during pregnancy. The purpose of the present paper is to summarize and evaluate the current evidence for the risk/benefit analysis of SSRI use in human pregnancy. The literature has been inconsistent. Although most studies h...
Saved in:
Main Authors: | Orna Diav-Citrin, Asher Ornoy |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Obstetrics and Gynecology International |
Online Access: | http://dx.doi.org/10.1155/2012/698947 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ankle edema after administration of selective serotonin reuptake inhibitors
by: Konstantinos Kontoangelos, et al.
Published: (2018-06-01) -
Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?
by: Kim Chau, et al.
Published: (2012-01-01) -
Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01) -
Selective Serotonin Reuptake Inhibitors: Antimicrobial Activity Against ESKAPEE Bacteria and Mechanisms of Action
by: Thiago Hideo Endo, et al.
Published: (2025-01-01) -
Methotrexate in pregnancy: still many unanswered questions
by: Corinna Weber-Schoendorfer, et al.
Published: (2023-03-01)